The Transcription Factor NRF2
Biology, Disease and Translational Opportunities
- 1st Edition - March 1, 2027
- Latest edition
- Editors: Narendra Kumar Sharma, Yasmin Ahmad
- Language: English
The Transcription Factor NRF2: Biology, Disease and Translational Opportunities offers a detailed and authoritative reference on NRF2, a key regulator of cellular defence agains… Read more
Description
Description
The Transcription Factor NRF2: Biology, Disease and Translational Opportunities equips researchers, clinicians, and advanced students with critical knowledge to understand NRF2’s multifaceted functions and therapeutic potential. It serves as an essential guide for advancing research and strategies targeting NRF2 in a diverse array of medical conditions, and is an ideal reference for those working across cell biology, molecular biology, biomedicine and related fields.
Key features
Key features
- Explores NRF2 as a therapeutic target across a diverse range of diseases
- Considers the dual nature of NRF2 as both detrimental and beneficial in various disease states
- Highlights clinical applications and drug development strategies
- Investigates the latest experimental techniques and AI-based tools for studying NRF2
Readership
Readership
Table of contents
Table of contents
2. Molecular structure and regulation of NRF2 and NRF2-KEAP1-PGAM5 ternary complex at the outer mitochondrial membrane
3. NRF2 targets and antioxidant response
4. NRF2 in cellular defense mechanisms, pharmacological activators and inhibitors and their relevance in disease
5. NRF2 in metabolic regulation and its crosstalk with other signalling pathways
6. Recent advances in experimental techniques and methodologies for studying NRF2 and AI-based/systems biology tools
7. NRF2 in disease states: cancer—dual roles in tumorigenesis and chemoresistance
8. NRF2 in disease states: chronic inflammatory and autoimmune diseases
9. NRF2 in disease states: neurodegenerative disorders—Alzheimer’s and Parkinson’s Disease
10. NRF2 in disease states: cardiovascular diseases
11. NRF2 in disease states: diabetes, metabolic syndrome, MASH and MASLD
12. Therapeutic implications and drug development
Product details
Product details
- Edition: 1
- Latest edition
- Published: March 1, 2027
- Language: English
About the editors
About the editors
NS
Narendra Kumar Sharma
Dr. Narendra Kumar Sharma is currently an Assistant Professor in the Department of Biosciences and Biotechnology at Banasthali Vidyapith, Rajasthan, India. He has a PhD from the Defence Institute of Physiology and Allied Sciences (DRDO) and completed his post-doctoral training at the Guangzhou Institutes of Biomedicine and Health (GIBH) in China and at the Federal University of Sao Paulo (UNIFESP) in Brazil. He has more than eight years of teaching and research experience. He has published more than 30 research articles in peer-reviewed international journals, has authored and edited books, and has presented his research at various international conferences in India, Brazil, China, USA, and Germany. He has also been awarded. He has been awarded several prestigious awards such as the Dr. T S Vasundhara Memorial Best Paper Award and the Young Scientist and Best Innovator Award by Microbiologist Society of India.
YA
Yasmin Ahmad
Dr. Yasmin Ahmad is currently a Senior Scientist at the Peptide and Proteomics Division of DIPAS, India. She earned her Ph.D. in Analytical Chemistry from Aligarh Muslim University (AMU), where she also completed a prestigious Senior Research Fellowship under CSIR.
Dr. Ahmad has published over 45 original research articles in prestigious peer reviewed journals. Her impactful research has garnered recognition in the form of numerous awards, such as the Surg. Rear Admiral M.S. Malhotra Research Prize (2013), the Dr. T.S. Vasundhara Memorial Best Paper Award (2015), and the VIRA Outstanding Scientist Award in Analytical Chemistry (2017), Smt. Kusum Sharma Award for a Young Woman Scientist, IABS (2017), Laboratory Scientist of the year (2021), Marie Curie Excellence Award (2022). In addition to her research, Dr. Ahmad serves on the editorial boards of several leading journals, including the “Journal of Translational Proteomics Research” and “World Journal of Pharmacy and Pharmaceutical Sciences”.